04:11 PM EDT, 03/18/2025 (MT Newswires) -- Nvidia ( NVDA ) introduced its new Spectrum-X and Quantum-X silicon photonics product lines on Tuesday, saying that these will drive growth on a massive scale for next-generation factories using artificial intelligence. The new switches also were developed to combine electronic circuits and optical communications at scale while reducing energy consumption and operational...

04:12 PM EDT, 03/18/2025 (MT Newswires) -- Aaron Edward Frederick Rankin, 10% Owner, Director, on March 17, 2025, sold 23,646 shares in Sprout Social ( SPT ) for $581,124. Following the Form 4 filing with the SEC, Rankin has control over a total of 42,122 Class A common shares of the company, with 42,122 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1517375/000151737525000038/xslF345X05/wk-form4_1742328118.xml...

04:04 PM EDT, 03/18/2025 (MT Newswires) -- Daniel Paul Franzetti, Executive Vice President and Chief Administrative Officer, on March 15, 2025, sold 12,991 shares in Cna Financial ( CNA ) for $637,338. Following the Form 4 filing with the SEC, Franzetti has control over a total of 75,612 common shares of the company, with 75,612 shares held directly. SEC Filing:...

(Reuters) - Sarepta Therapeutics said on Tuesday that a 16-year-old boy died from acute liver failure months after receiving the company's U.S-approved gene therapy for a rare muscular dystrophy. The patient underwent treatment in December with Sarepta's therapy, called Elevidys, the company told Reuters in an emailed statement. Elevidys is the only FDA-approved gene therapy for Duchenne muscular dystrophy (DMD)...